Theresa Tse
Vorsitzender bei SINO BIOPHARMACEUTICAL LIMITED
Vermögen: 2 Mio $ am 30.04.2024
Aktive Positionen von Theresa Tse
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SINO BIOPHARMACEUTICAL LIMITED | Vorsitzender | 30.06.2015 | - |
KAROLINSKA DEVELOPMENT AB | Direktor/Vorstandsmitglied | 28.11.2017 | - |
Independent Dir/Board Member | 28.11.2017 | - | |
Golden Sword Ventures Ltd. | Direktor/Vorstandsmitglied | - | - |
Chia Tai-Tianqing Pharmaceutical Holdings Co., Ltd. | Direktor/Vorstandsmitglied | - | - |
Sino Biopharmaceutical (Beijing) Ltd.
Sino Biopharmaceutical (Beijing) Ltd. Miscellaneous Commercial ServicesCommercial Services Sino Biopharmaceutical (Beijing) Ltd. is an investment holding company. Its sole asset is its 33.6% interest in Beijing Tide Pharmaceutical Co., Ltd., a pharmaceutical company established in China with limited liability, which develops, manufactures, and market pharmaceutical products. Sino Biopharmaceutical (Beijing) was founded on December 31, 2007 and is headquartered in Hong Kong. | Direktor/Vorstandsmitglied | - | - |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The private company was founded in 1969, and the CEO is Kang Xin Yu. | Direktor/Vorstandsmitglied | - | - |
invoX Pharma Ltd.
invoX Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., invoX Pharma Ltd. is a British biopharmaceutical company. The private company is based in Kingston-upon-Thames, UK. The company was founded in 2021. Benjamin Toogood has been the CEO of the company since 2023. | Direktor/Vorstandsmitglied | - | - |
Chia Tai Life Technology Ltd. | Direktor/Vorstandsmitglied | - | - |
Yun On Investment Holding Ltd. | Direktor/Vorstandsmitglied | - | - |
░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Karriereverlauf von Theresa Tse
Ehemalige bekannte Positionen von Theresa Tse
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | ░░░░░░░░░░ |
░░░░░░░ ░░░░ ░░░ ░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Ausbildung von Theresa Tse
The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Statistik
International
Hong Kong | 6 |
China | 6 |
Cayman Islands | 2 |
Operativ
Director/Board Member | 12 |
Chairman | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 4 |
Finance | 3 |
Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
SINO BIOPHARMACEUTICAL LIMITED | Health Technology |
TIANJIN BINHAI TEDA LOGISTICS (GROUP) CORPORATION LIMITED | Transportation |
KAROLINSKA DEVELOPMENT AB | Finance |
Private Unternehmen | 10 |
---|---|
Golden Sword Ventures Ltd. | |
Chia Tai-Tianqing Pharmaceutical Holdings Co., Ltd. | |
Sino Biopharmaceutical (Beijing) Ltd.
Sino Biopharmaceutical (Beijing) Ltd. Miscellaneous Commercial ServicesCommercial Services Sino Biopharmaceutical (Beijing) Ltd. is an investment holding company. Its sole asset is its 33.6% interest in Beijing Tide Pharmaceutical Co., Ltd., a pharmaceutical company established in China with limited liability, which develops, manufactures, and market pharmaceutical products. Sino Biopharmaceutical (Beijing) was founded on December 31, 2007 and is headquartered in Hong Kong. | Commercial Services |
Beijing Tide Pharmaceutical Co., Ltd.
Beijing Tide Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Beijing Tide Pharmaceutical Co., Ltd. engages in research, development, manufacturing and sale of pharmaceutical products. The firm's products include kaifen flurbiprofen axetil injection, kaishi alprostadil injection, kaina beraprost sodium tablet and deyou pronase granules. The company was founded in May 1995 and is headquartered in Beijing, China. | Commercial Services |
Beijing Chia Tai Charity Foundation | |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The private company was founded in 1969, and the CEO is Kang Xin Yu. | Health Technology |
invoX Pharma Ltd.
invoX Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., invoX Pharma Ltd. is a British biopharmaceutical company. The private company is based in Kingston-upon-Thames, UK. The company was founded in 2021. Benjamin Toogood has been the CEO of the company since 2023. | Health Technology |
Chia Tai Life Technology Ltd. | |
Yun On Investment Holding Ltd. | |
France Investment (China 1) Group Ltd.
France Investment (China 1) Group Ltd. Financial ConglomeratesFinance France Investment (China 1) Group Ltd. operates as an investment holding company. The company is headquartered in Hongkong. | Finance |
- Börse
- Insiders
- Theresa Tse
- Erfahrung